Authors: Matthew T. Popovich, PhD et al ASA Monitor January 2024, Vol. 88, 28–29. Although anesthesiologists have always paid attention to blood pressure and its effects on both immediate and postoperative patient outcomes, only recently have anesthesiologists had better definitions and criteria to assess management of a patient’s blood pressure. The question for anesthesiologists and their […]
Read MoreAuthor: Patsy Newitt Becker’s ASC Review For ASCs, providing anesthesia in 2023 was a huge obstacle amid provider shortages and declining reimbursements. “Today’s shortage of anesthesia providers has been compounding for years and has turned into an incredible challenge for all,” Andrew Lovewell, CEO of Columbia (Mo.) Orthopaedic Group, told Becker’s. “Not only is it difficult to […]
Read MoreNew treatment for rare blood cancer The U.S. Food and Drug Administration (FDA) has approved Tibsovo (ivosidenib) for the treatment of adult patients with relapsed or refractory myelodysplastic syndromes (MDS) who have an isocitrate dehydrogenase-1 (IDH1) mutation. MDS is a rare form of blood cancer caused by mutations in bone marrow cells, leading to a […]
Read MoreAuthors: Zachariah P.G. Olufs, B.S. et al Anesthesiology December 2023. Background Carriers of mutations in the mitochondrial electron transport chain (mETC) are at increased risk of anesthetic-induced neurotoxicity. To investigate the neurotoxicity mechanism and to test preconditioning as a protective strategy, we used a Drosophila melanogaster model of Leigh syndrome. Model flies carried a mutation in ND23 (ND2360114) that encodes […]
Read MoreAUTHORS: Fritz, Bradley A. MD, MSCI et al Anesthesia & Analgesia June 2023. BACKGROUND: Machine learning models can help anesthesiology clinicians assess patients and make clinical and operational decisions, but well-designed human-computer interfaces are necessary for machine learning model predictions to result in clinician actions that help patients. Therefore, the goal of this study […]
Read More